Enlivex ENLV
NASDAQ ENLV
$1.47 -0.03 (-2.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enlivex (ENLV) Invested Capital (2017 - 2019)

Enlivex (ENLV) posted quarterly Invested Capital of $14000.0 for Q3 2019, down 39.13% year-over-year from $23000.0 in Q3 2018, and little changed quarter-over-quarter from $14000.0 in Q2 2019.

Enlivex (ENLV) Invested Capital (2017 - 2019) Analysis & Trends

Enlivex's Invested Capital history runs 3 years deep, the most recent figure standing at $14000.0 for Q3 2019.

  • In Q3 2019, Invested Capital fell 39.13% year-over-year to $14000.0; the TTM figure through Jun 2020 stood at $14000.0 (down 89.15% YoY), while the FY2018 annual figure was $78000.0, up 56.0% from the prior year.
  • Invested Capital for Q3 2019 stood at $14000.0, roughly flat from $14000.0 in the prior quarter.
  • The five-year high for Invested Capital was $78000.0 in Q4 2018, with the low at $14000.0 in Q1 2019.
  • The 3-year median for Invested Capital is $18500.0 (2018), against an average of $32166.7.
  • The sharpest annual moves came in 2018 and 2019: Invested Capital soared 56.0% in 2018, then plunged 39.13% in 2019.
  • Enlivex's Invested Capital stood at $50000.0 in 2017, then jumped by 56.0% to $78000.0 in 2018, then slumped by 82.05% to $14000.0 in 2019.
  • Business Quant data shows ENLV's Invested Capital at $14000.0 in Q3 2019, $14000.0 in Q2 2019, and $14000.0 in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 37.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 190.90 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 1.45 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - 380.00 Mn
10 Enlivex 4.51 Mn -1.25 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2019 14,000.00
Jun 30, 2019 14,000.00
Mar 31, 2019 14,000.00
Dec 31, 2018 78,000.00
Sep 30, 2018 23,000.00
Dec 31, 2017 50,000.00